V017-6459 Screening compound: N-butyl-2,4-dichloro-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

V017-6459 Screening compound: N-butyl-2,4-dichloro-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide
V017-6459 Screening compound: N-butyl-2,4-dichloro-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-6459
N-butyl-2,4-dichloro-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-6459

Molecular Formula

C28H31Cl2N5O3 (C28 H31 Cl2 N5 O3)

Compound Name

N-butyl-2,4-dichloro-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

IUPAC name

N-butyl-24-dichloro-N-(2-{4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl}-2-oxoethyl)benzamide

SMILES

CCCCN(CC(N(CC1)CCN1c(cc1)nnc1-c(cc1)ccc1OC)=O)C(c(ccc(Cl)c1)c1Cl)=O

InChI

InChI=1S/C28H31Cl2N5O3/c1-3-4-13-35(28(37)23-10-7-21(29)18-24(23)30)19-27(36)34-16-14-33(15-17-34)26-12-11-25(31-32-26)20-5-8-22(38-2)9-6-20/h5-12,18H,3-4,13-17,19H2,1-2H3

InChI Key

AXBIYNAPFCGAFE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14476839

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

556.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.124

Distribution Coefficient, logD

5.122

Water Solubility, LogSw

-5.59

Polar Surface Area

64.559

Acid Dissociation Constant (pKa)

22.78

Base Dissociation Constant (pKb)

5.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.70

V017-6459 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V017-6459 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-6459?
Check Price and Availability of V017-6459, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-6459 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-6459
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-6459
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-6459 available by request